Morgan Stanley’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $15.7M | Buy |
|
|||||
|
2023
Q1 | $5.83M | Sell |
|
|||||
|
2022
Q4 | $7.39M | Sell |
|
|||||
|
2022
Q3 | $5.61M | Buy |
|
|||||
|
2022
Q2 | $4.04M | Buy |
|
|||||
|
2022
Q1 | $2.21M | Buy |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $891K | Buy |
|
|||||
|
2021
Q2 | $948K | Buy |
|
|||||
|
2021
Q1 | $19K | Sell |
|
|||||
|
2020
Q4 | $351K | Buy |
|
|||||
|
2020
Q3 | $32K | Sell |
|
|||||
|
2020
Q2 | $66K | Buy |
|
|||||
|
2020
Q1 | $33K | Sell |
|
|||||
|
2019
Q4 | $111K | Buy |
|
|||||
|
2019
Q3 | $32K | Sell |
|
|||||
|
2019
Q2 | $103K | Buy |
|
|||||
|
2019
Q1 | $111K | Sell |
|
|||||
|
2018
Q4 | $751K | Buy |
|
|||||
|
2018
Q3 | $1.58M | Buy |
|
|||||
|
2018
Q2 | $1.47M | Buy |
|
|||||
|
2018
Q1 | $936K | Sell |
|
|||||
|
2017
Q4 | $1.3M | Sell |
|
|||||
|
2017
Q3 | $2.26M | Buy |
|
|||||
|
2017
Q2 | $1.88M | Buy |
|
|||||
|
2017
Q1 | $1.2M | Sell |
|
|||||
|
2016
Q4 | $1.45M | Buy |
|
|||||
|
2016
Q3 | $383K | Buy |
|
|||||
|
2016
Q2 | $97K | Sell |
|
|||||
|
2016
Q1 | $220K | Buy |
|
|||||
|
2015
Q4 | $424K | Buy |
|
|||||
|
2015
Q3 | $124K | Sell |
|
|||||
|
2015
Q2 | $442K | Buy |
|